Oncotag offers solutions in precision medicine using patented oncology biomarkers. Its technology allows the prescription of treatments tailored to the patient’s genetic profile, which increases life expectancy and reduces the cost and time of treatment.
BUSINESS MODEL: B2C
PRODUCT: In development
For further information, please contact us.
Back to Investors page